Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITIONS AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. GOVERNMENT REGULATIONS

3.3.1. U.S. FDA
3.3.2. Europe CE Mark
3.3.3. Ministry of Health, Labor, and Welfare (MHLW)

3.4. REIMBURSEMENT SCENARIOS
3.5. CLINICAL TRIALS
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rise in prevalence of chronic diseases
3.6.1.2. Efficient and convenient technique
3.6.1.3. Growing awareness

3.6.2. Restraints

3.6.2.1. Budget constraints
3.6.2.2. Lack of trained professionals

3.6.3. Opportunities

3.6.3.1. Technological advancements
3.6.3.2. Development of skilled professionals

Chapter: 4 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE

4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. SPECT

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Standalone SPECT

4.3.4.1. Market size and forecast

4.3.5. Hybrid SPECT

4.3.5.1. Market size and forecast

4.4. PET

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Standalone PET

4.4.4.1. Market size and forecast

4.4.5. Hybrid PET

4.4.5.1. Market size and forecast

Chapter: 5 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION

5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. NEUROLOGY

5.3.1. Market size and forecast

5.4. ONCOLOGY

5.4.1. Market size and forecast

5.5. CARDIOLOGY

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER

6.1. OVERVIEW
6.2. MARKET SIZE AND FORECAST
6.3. HOSPITALS

6.3.1. Market size and forecast

6.4. IMAGING CENTERS

6.4.1. Market size and forecast

6.5. ACADEMIC AND RESEARCH INSTITUTES

6.5.1. Market size and forecast

Chapter: 7 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. MARKET SIZE AND FORECAST
7.3. NORTH AMERICA

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. U.S.
7.3.5. Canada
7.3.6. Mexico

7.4. EUROPE

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Germany
7.4.5. France
7.4.6. UK
7.4.7. Italy
7.4.8. Spain
7.4.9. Russia
7.4.10. Rest of Europe

7.5. ASIA-PACIFIC

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Japan
7.5.5. China
7.5.6. Australia
7.5.7. India
7.5.8. Rest of Asia-Pacific

7.6. LAMEA

7.6.1. Key market trends
7.6.2. Key growth factors and opportunities
7.6.3. Market size and forecast
7.6.4. Brazil
7.6.5. Turkey
7.6.6. Saudi Arabia
7.6.7. Republic of South Africa
7.6.8. Argentina
7.6.9. Rest of LAMEA

Chapter: 8 COMPANY PROFILES

8.1. KONINKLIJKE PHILIPS N.V.

8.1.1. Overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. SIEMENS AKTIENGESELLSCHAFT

8.2.1. Overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. GENERAL ELECTRIC COMPANY

8.3.1. Overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. DIGIRAD CORPORATION

8.4.1. Overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. MEDISO MEDICAL IMAGING SYSTEMS, LTD.

8.5.1. Overview
8.5.2. Operating business segments
8.5.3. Key strategic moves and developments

8.6. TOSHIBA CORPORATION

8.6.1. Overview
8.6.2. Operating business segments
8.6.3. Business performance

8.7. BOZLU HOLDING

8.7.1. Overview
8.7.2. Key strategic moves and developments

8.8. NEUSOFT CORPORATION

8.8.1. Overview
8.8.2. Operating business segments
8.8.3. Key strategic moves and developments

8.9. COMPAA MEXICANA DE RADIOLOGA CGR, S.A. DE C.V.

8.9.1. Overview

8.10. SURGICEYE GMBH

8.10.1. Overview
8.10.2. Key strategic moves and developments